International Clinical Psychopharmacology (ICP)
Journal Descriptions
International Clinical Psychopharmacology provides an essential link between research and clinical practice throughout psychopharmacology. It reports on studies in human subjects, both healthy volunteers and patients, which relate the effects of drugs on psychological processes. A major objective of the journal is to publish fully refereed papers which throw light on the ways in which the study of psychotropic drugs can increase our understanding of psychopharmacology. To this end the journal publishes results of early Phase I and II studies, as well as those of controlled clinical trials of psychotropic drugs in Phase II and IV. Other topics covered include the epidemiology of psychotropic drug prescribing and drug taking, the sociology of psychotropic drugs including compliance, and research into the safety and adverse effects of these compounds. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.
International Clinical Psychopharmacology (ICP) is :-
-
International, Peer-Reviewed, Open Access, Refereed, Psychopharmacology, Psychotropic Drugs, Controlled Clinical Trials, Phase I and II Studies, Epidemiology, Drug Prescribing, Drug Taking, Sociological Aspects, Safety, Psychological Processes, Drug Effects, Mental Health , Online or Print , Half-Yearly Journal
- UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0268-1315, E-ISSN: 1473-5857, Established: 1986, Impact Factor: 2.1
- Does Not Provide Crossref DOI
-
Indexed in: Scopus, WoS, PubMed
-
Not indexed in DOAJ, UGC CARE
